Concepedia

Rajesh Narwal

RN

24

Publications

1.8K

Citations

19

H-Index

2010

Active since

Affiliations

AstraZeneca (United States)(Current)

Sidney Kimmel Comprehensive Cancer Center

Columbia University Irving Medical Center

Memorial Sloan Kettering Cancer Center

Johns Hopkins Medicine

Rajesh Narwal is an author at AstraZeneca (United States) specializing in medicine, oncology, and pharmacology.

Top concepts

Publications per year

2010–2019

24

Publications

24

Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study

Scott Antonia, Sarah B. Goldberg, Ani Sarkis Balmanoukian et al. · The Lancet Oncology · 2016 · 589 citations · Full text

, , +7

A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition

Chang Gong, Oleg Milberg, Bing Wang et al. · Journal of The Royal Society Interface · 2017 · 159 citations · Full text

Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status

Paul Baverel, Vincent F. S. Dubois, Chao Yu Jin et al. · Clinical Pharmacology & Therapeutics · 2017 · 148 citations · Full text

Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo

Darren J. Schofield, Lorraine Irving, Laura Calò et al. · Neurobiology of Disease · 2019 · 110 citations · Full text

A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint Blockade

Oleg Milberg, Chang Gong, Mohammad Jafarnejad et al. · Scientific Reports · 2019 · 96 citations · Full text

Rows per page

1–5 of 24